ライフサイエンスコーパス: swollen joint

1 base guidelines on the management of the hot-swollen joint.

2 ednisone because it helps control tender and swollen joints.

3 r levels of radiologic damage, and had fewer swollen joints.

4 igoarthritis was defined as <5 tender and/or swollen joints.

5 ntly more tender joints (17 versus 11), more swollen joints (8 versus 7), more frequent rheumatoid fa

6 ges 18-70 years and had active PsA (> or = 3 swollen joints and > or = 3 tender joints) despite treat

7 nt from baseline in the number of tender and swollen joints and at least three of five other importan

8 nt from baseline in the number of tender and swollen joints and at least three other important domain

9 % reduction in the number of both tender and swollen joints and improvement in at least three of five

10 autoimmune disease characterized by painful swollen joints and significant disabilities.

11 ber of tender joints, 1.05 for the number of swollen joints, and 1.20 for the ESR).

12 rly diabetes mellitus or hypertension), many swollen joints, and a high cumulative dose of glucocorti

13 +)Th17 cells also correlated with numbers of swollen joints as late as one year post-therapy.

14 gest that the first abnormality to appear in swollen joints associated with spondyloarthropathy is an

15 entage reduction in the number of tender and swollen joints at 6 months was 56% and 47% in the 25-mg

16 vels, the presence of nodules, and number of swollen joints at baseline were all predictive of radiog

17 percent reduction in the number of tender or swollen joints at three months was 61 percent, as compar

18 RA had no change in the number of painful or swollen joints but had significant reductions in self-re

19 ve psoriatic arthritis (>/=5 tender and >/=5 swollen joints, C-reactive protein >/=3.0 mg/L) were ran

20 ined remission (defined as DAS28 <2.6 with a swollen joint count </=four, persisting for at least 24

21 ne (P = 0.005) and changes at 2 years in the swollen joint count (P = 0.002), total skin score (P = 0

22 nder joint count (TJC) using 68 joints and a swollen joint count (SJC) using 66 joints (66/68-joint c

23 (mean tender/painful joint count 29.4, mean swollen joint count 17.4, mean erythrocyte sedimentation

24 disease-modifying antirheumatic drugs; mean swollen joint count 8.6-10.4).

25 Swollen joint count also fell (-2.69 vs -0.53; mean diff

26 pects of PSPP were related to depression and swollen joint count but not functional fitness.

27 ), while a combination of MMP-3, CTX-II, and swollen joint count formed the best longitudinal AUC mod

28 ve protein level and an increase in the mean swollen joint count were noted during the study period.

29 The Ritchie Articular Index, swollen joint count, and Disease Activity Score were sig

30 ician's assessments of disease activity, the swollen joint count, and function (by Health Assessment

31 onnaire Disability Index, total Sharp score, swollen joint count, and presence of osteophytes (osteoa

32 : (a) when scores on the tender joint count, swollen joint count, CRP (in mg/dl), and patient global

33 The swollen joint count, physical function, and patient-asse

34 A 70-90% reduction in the swollen joint count, tender joint count, and C-reactive

35 moking status, HAQ score, RF positivity, and swollen joint counts (HR 3.3 [95% CI 1.4-7.6]).

36 Higher swollen joint counts and higher average C-reactive prote

37 ynovial fluid correlated with the tender and swollen joint counts and the activity scores on the 28-j

38 f 20% improvement (ACR20) and the tender and swollen joint counts at the end of treatment were the pr

39 tivity Score, and > or =50% decreases in the swollen joint counts during the first 2 years of followu

40 less than 5% improvement in both tender and swollen joint counts entered masked early-escape and wer

41 Mean reductions in tender and swollen joint counts in patients receiving alefacept plu

42 nalyzable" cases (paired data for tender and swollen joint counts plus > or =3 of the 5 secondary cri

43 ere patients with paired data for tender and swollen joint counts plus at least 3 of the following cr

44 naire score, rheumatoid factor, nodules, and swollen joint counts were not.

45 easure scored as 1 or less (e.g., tender and swollen joint counts, C-reactive protein [CRP] level, an

46 Outcome measures including tender and swollen joint counts, pain assessment on a 10-point visu

47 ues for rheumatoid factor and the tender and swollen joint counts.

48 Eighty-four subjects (14.0%) had > or =1 swollen joint, designated as IA on joint examination.

49 Adults with two or more swollen joints for at least 4 weeks were recruited from

50 comes assessed were the number of tender and swollen joints, grip strength, and the erythrocyte sedim

51 ts and 13 patients, respectively, and missed swollen joints in 11 patients and 2 patients, respective

52 pared with those in 2000: median 12 versus 5 swollen joints, Larsen radiographic score 20 versus 3, e

53 der joints (n = 29) and 27% of patients with swollen joints (n = 23).

54 ); and 4) assessor-only (median of number of swollen joints, number of tender joints, and global stat

55 ted: 1) ACR-N (lowest of 3 values: number of swollen joints, number of tender joints, and median of t

56 sex, current smokers had significantly fewer swollen joints (OR 0.61, 95% CI 0.37-0.98).

57 associated with a lower number of tender and swollen joints (P < 0.05) and a lower score for the phys

58 nt-reported warm joint, any patient-reported swollen joint, patient-reported pain at rest score of >3

59 were the number of tender joints, number of swollen joints, physician and patient global assessments

60 ents who present with an acutely painful and swollen joint, prompt identification and treatment of se

61 IA was defined as > or =1 swollen joint suggestive of synovitis on joint examinati

62 who is feverish and toxic, with a single hot swollen joint that has limited movement and is often rig

63 weekly dosing when assessed by the number of swollen joints, the investigator and patient assessments

64 The numbers of tender and swollen joints, the Visual Analog Scale (VAS) scores for

65 RDs was increased according to protocol, and swollen joints were injected with triamcinolone acetonid

66 flare, joint pain at rest, warm joints, and swollen joints were most strongly associated with presen

67 Twenty-three patients with active RA (>5 swollen joints) were enrolled into a randomized, double-

68 unt (at least 10 tender/painful joints and 7 swollen joints) were stratified according to DMARD intol

69 e of 68 tender joints and four or more of 66 swollen joints, who were refractory or intolerant to pre